{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:53:43Z","timestamp":1791176023245,"version":"4.1.0"},"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T00:00:00Z","timestamp":1402358400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0096360","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T23:57:05Z","timestamp":1402444625000},"page":"e96360","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":60,"title":["Identification of Continuous Human B-Cell Epitopes in the VP35, VP40, Nucleoprotein and Glycoprotein of Ebola Virus"],"prefix":"10.1371","volume":"9","author":[{"given":"Pierre","family":"Becquart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanel","family":"Mahlak\u00f5iv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieudonn\u00e9","family":"Nkoghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,6,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00705-010-0600-9","article-title":"Clarification and guidance on the proper usage of virus and virus species names","volume":"155","author":"JH Kuhn","year":"2010","journal-title":"Arch Virol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-3-7091-9300-6_8","article-title":"Molecular biology and evolution of filoviruses","volume":"Suppl 7","author":"H Feldmann","year":"1993","journal-title":"Arch Virol"},{"key":"ref3","unstructured":"Sanchez A, Khan AS, Zaki S, Nabel GJ, Kziazeck TG, <etal>et al<\/etal>.. (2001) Filoridae: Marburg and Ebola viruses. In: Knipe DS., Howley, P.M., Griffin, D.E., Lamb, R.A., Martin, M.A., Roizman, B., Straus, S.E., editor. Fields Virology Lippincott Williams and Wilkins, Philadelphia, PA. pp. 1279\u20131304."},{"key":"ref4","first-page":"247","article-title":"Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO\/International Study Team","volume":"56","journal-title":"Bull World Health Organ"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1086\/514306","article-title":"The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit","volume":"179 Suppl 1","author":"AS Khan","year":"1999","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1086\/514290","article-title":"Ebola hemorrhagic fever outbreaks in Gabon, 1994\u20131997: epidemiologic and health control issues","volume":"179 Suppl 1","author":"AJ Georges","year":"1999","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.1092528","article-title":"Multiple Ebola virus transmission events and rapid decline of central African wildlife","volume":"303","author":"EM Leroy","year":"2004","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/S0140-6736(00)02405-3","article-title":"Human asymptomatic Ebola infection and strong inflammatory response","volume":"355","author":"EM Leroy","year":"2000","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2249.2001.01517.x","article-title":"Early immune responses accompanying human asymptomatic Ebola infections","volume":"124","author":"EM Leroy","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2249.2002.01800.x","article-title":"Inflammatory responses in Ebola virus-infected patients","volume":"128","author":"S Baize","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.4049\/jimmunol.180.6.4058","article-title":"Functional CD8+ T cell responses in lethal Ebola virus infection","volume":"180","author":"SB Bradfute","year":"2008","journal-title":"J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/7422","article-title":"Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients","volume":"5","author":"S Baize","year":"1999","journal-title":"Nat Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1086\/514313","article-title":"ELISA for the detection of antibodies to Ebola viruses","volume":"179 Suppl 1","author":"TG Ksiazek","year":"1999","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1086\/520609","article-title":"Laboratory diagnosis of Ebola hemorrhagic fever during an outbreak in Yambio, Sudan, 2004","volume":"196 Suppl 2","author":"CO Onyango","year":"2007","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3201\/eid1507.090402","article-title":"Immunoglobulin G in Ebola outbreak survivors, Gabon","volume":"15","author":"N Wauquier","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1086\/514321","article-title":"Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995","volume":"179 Suppl 1","author":"TG Ksiazek","year":"1999","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e9126","DOI":"10.1371\/journal.pone.0009126","article-title":"High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon","volume":"5","author":"P Becquart","year":"2010","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1128\/JVI.73.7.6024-6030.1999","article-title":"Ebola virus can be effectively neutralized by antibody produced in natural human infection","volume":"73","author":"T Maruyama","year":"1999","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/viro.1997.8529","article-title":"Emergence of subtype Zaire Ebola virus in Gabon","volume":"232","author":"V Volchkov","year":"1997","journal-title":"Virology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0140-6736(02)07796-6","article-title":"Re-emergence of ebola haemorrhagic fever in Gabon","volume":"359","author":"EM Leroy","year":"2002","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"JE Lee","year":"2008","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.287.5458.1664","article-title":"Epitopes involved in antibody-mediated protection from Ebola virus","volume":"287","author":"JA Wilson","year":"2000","journal-title":"Science"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jviromet.2007.02.004","article-title":"Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens","volume":"143","author":"S Shahhosseini","year":"2007","journal-title":"J Virol Methods"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.1200409109","article-title":"Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease","volume":"109","author":"JM Dye","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0042-6822(85)90236-3","article-title":"Descriptive analysis of Ebola virus proteins","volume":"147","author":"LH Elliott","year":"1985","journal-title":"Virology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0168-1702(95)00080-1","article-title":"Differentiation of filoviruses by electron microscopy","volume":"39","author":"TW Geisbert","year":"1995","journal-title":"Virus Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"13871","DOI":"10.1073\/pnas.250277297","article-title":"A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding","volume":"97","author":"RN Harty","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"15936","DOI":"10.1073\/pnas.2533915100","article-title":"In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding","volume":"100","author":"RG Panchal","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1743-422X-3-31","article-title":"Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology","volume":"3","author":"RF Johnson","year":"2006","journal-title":"Virol J"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1128\/JVI.76.10.4855-4865.2002","article-title":"Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP","volume":"76","author":"T Noda","year":"2002","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1107\/S0907444900004388","article-title":"Crystallization and preliminary X-ray analysis of the matrix protein from Ebola virus","volume":"56","author":"A Dessen","year":"2000","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1093\/emboj\/19.16.4228","article-title":"Crystal structure of the matrix protein VP40 from Ebola virus","volume":"19","author":"A Dessen","year":"2000","journal-title":"EMBO J"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1128\/JVI.75.11.5205-5214.2001","article-title":"Ebola virus VP40-induced particle formation and association with the lipid bilayer","volume":"75","author":"LD Jasenosky","year":"2001","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.cell.2013.07.015","article-title":"Structural rearrangement of ebola virus VP40 begets multiple functions in the virus life cycle","volume":"154","author":"ZA Bornholdt","year":"2013","journal-title":"Cell"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/jmbi.2000.3822","article-title":"Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus","volume":"300","author":"RW Ruigrok","year":"2000","journal-title":"J Mol Biol"},{"key":"ref36","first-page":"274","article-title":"[Monoclonal antibodies to Marburg virus proteins and their immunochemical characteristics]","volume":"43","author":"IA Razumov","year":"1998","journal-title":"Vopr Virusol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/78645","article-title":"Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury","volume":"6","author":"ZY Yang","year":"2000","journal-title":"Nat Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1099\/0022-1317-82-12-2839","article-title":"Biosynthesis and role of filoviral glycoproteins","volume":"82","author":"H Feldmann","year":"2001","journal-title":"J Gen Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1128\/JVI.79.2.918-926.2005","article-title":"Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha","volume":"79","author":"A Yonezawa","year":"2005","journal-title":"J Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1086\/520581","article-title":"Epitopes required for antibody-dependent enhancement of Ebola virus infection","volume":"196 Suppl 2","author":"A Takada","year":"2007","journal-title":"J Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.vaccine.2006.09.076","article-title":"Protective efficacy of neutralizing antibodies against Ebola virus infection","volume":"25","author":"A Takada","year":"2007","journal-title":"Vaccine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e1575","DOI":"10.1371\/journal.pntd.0001575","article-title":"Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection","volume":"6","author":"X Qiu","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1086\/514280","article-title":"Recombinant human monoclonal antibodies to Ebola virus","volume":"179 Suppl 1","author":"T Maruyama","year":"1999","journal-title":"J Infect Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1128\/JVI.76.12.6408-6412.2002","article-title":"Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody","volume":"76","author":"PW Parren","year":"2002","journal-title":"J Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.ppat.0030009","article-title":"Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys","volume":"3","author":"WB Oswald","year":"2007","journal-title":"PLoS Pathog"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e36192","DOI":"10.1371\/journal.pone.0036192","article-title":"Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever","volume":"7","author":"A Marzi","year":"2012","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1073\/pnas.93.8.3602","article-title":"The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing","volume":"93","author":"A Sanchez","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/viro.1995.0052","article-title":"GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases","volume":"214","author":"VE Volchkov","year":"1995","journal-title":"Virology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"9596","DOI":"10.1128\/JVI.00784-09","article-title":"Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins","volume":"83","author":"O Reynard","year":"2009","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e1001098","DOI":"10.1371\/journal.ppat.1001098","article-title":"Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein","volume":"6","author":"JR Francica","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"18137","DOI":"10.1073\/pnas.0909696106","article-title":"Glycans on influenza hemagglutinin affect receptor binding and immune response","volume":"106","author":"CC Wang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0168-1702(01)00258-1","article-title":"Symposium on Marburg and Ebola viruses","volume":"80","author":"HD Klenk","year":"2001","journal-title":"Virus Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1128\/JVI.05549-11","article-title":"Structure of an antibody in complex with its mucin domain linear epitope that is protective against Ebola virus","volume":"86","author":"D Olal","year":"2012","journal-title":"J Virol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/jvi.76.5.2518-2528.2002","article-title":"Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence","volume":"76","author":"G Simmons","year":"2002","journal-title":"J Virol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/JVI.79.1.547-553.2005","article-title":"Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway","volume":"79","author":"NJ Sullivan","year":"2005","journal-title":"J Virol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1128\/JVI.79.8.4793-4805.2005","article-title":"Comprehensive analysis of ebola virus GP1 in viral entry","volume":"79","author":"B Manicassamy","year":"2005","journal-title":"J Virol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"13378","DOI":"10.1128\/JVI.01170-07","article-title":"Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity","volume":"81","author":"RL Kaletsky","year":"2007","journal-title":"J Virol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.virol.2008.10.029","article-title":"Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein","volume":"383","author":"JR Francica","year":"2009","journal-title":"Virology"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1128\/JVI.02098-06","article-title":"Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines","volume":"81","author":"W Dowling","year":"2007","journal-title":"J Virol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"15951","DOI":"10.1074\/jbc.M601796200","article-title":"Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor","volume":"281","author":"JH Kuhn","year":"2006","journal-title":"J Biol Chem"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"7702","DOI":"10.1128\/JVI.02433-06","article-title":"Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events","volume":"81","author":"MA Brindley","year":"2007","journal-title":"J Virol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.virusres.2013.05.004","article-title":"Mapping of conserved and species-specific antibody epitopes on the Ebola virus nucleoprotein","volume":"176","author":"K Changula","year":"2013","journal-title":"Virus Res"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/514318","article-title":"Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit","volume":"179 Suppl 1","author":"AK Rowe","year":"1999","journal-title":"J Infect Dis"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/infdis\/jit162","article-title":"Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu)","volume":"208","author":"A Sobarzo","year":"2013","journal-title":"J Infect Dis"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMc1300266","article-title":"Persistent immune responses after Ebola virus infection","volume":"369","author":"A Sobarzo","year":"2013","journal-title":"N Engl J Med"},{"key":"ref66","first-page":"13","article-title":"The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports\u2013principles and applications","volume":"267","author":"R Frank","year":"2002","journal-title":"J Immunol Methods"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/322747a0","article-title":"Continuous and discontinuous protein antigenic determinants","volume":"322","author":"DJ Barlow","year":"1986","journal-title":"Nature"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1006\/meth.1996.0054","article-title":"Mapping Epitope Structure and Activity: From One-Dimensional Prediction to Four-Dimensional Description of Antigenic Specificity","volume":"9","author":"MHV Van Regenmortel","year":"1996","journal-title":"Methods"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1086\/428128","article-title":"Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy","volume":"40","author":"H Toyoda","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1128\/JCM.28.2.211-215.1990","article-title":"Effect of primary Epstein-Barr virus infection on human herpesvirus 6, cytomegalovirus, and measles virus immunoglobulin G titers","volume":"28","author":"A Linde","year":"1990","journal-title":"J Clin Microbiol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3201\/eid0301.970107","article-title":"Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon","volume":"3","author":"MC Georges-Courbot","year":"1997","journal-title":"Emerg Infect Dis"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1099\/0022-1317-83-1-67","article-title":"Sequence analysis of the GP, NP, VP40 and VP24 genes of Ebola virus isolated from deceased, surviving and asymptomatically infected individuals during the 1996 outbreak in Gabon: comparative studies and phylogenetic characterization","volume":"83","author":"EM Leroy","year":"2002","journal-title":"J Gen Virol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"17123","DOI":"10.1073\/pnas.0704076104","article-title":"Isolates of Zaire ebolavirus from wild apes reveal genetic lineage and recombinants","volume":"104","author":"TJ Wittmann","year":"2007","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0096360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T21:30:49Z","timestamp":1597959049000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0096360"}},"subtitle":[],"editor":[{"given":"Jens H.","family":"Kuhn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,10]]},"references-count":73,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0096360","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,10]]}}}